Study Questions Value of Interim PET Imaging to Guide Frontline Hodgkin Treatment

(MedPage Today) -- HOUSTON -- Interim PET-CT imaging (PET2) had almost no impact on clinical decision-making for Hodgkin lymphoma treated with brentuximab vedotin (Adcetris), according to a small clinical study reported here. One of 40 patients...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news